Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Long-Term Debt Issuances (2023 - 2024)

Updated

Adaptin Bio's Long-Term Debt Issuances was $1 million in FY2024, compared with $80,915 in FY2023.

Analysis

Adaptin Bio (APTN) Long-Term Debt Issuances (2023 - 2024) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $80,915 in FY2023 and $304.00 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Adaptin Bio 56.76 Mn 54.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 25,192.00
Jun 30, 2024 222,542.00
Mar 31, 2024 90,000.00
Dec 31, 2023 58,347.00
API Access

Adaptin Bio Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=APTN&period=max&api_key=YOUR_API_KEY